In addition to a difference in tumor suppressor pathway, many pathways related to carcinogenesis and progression showed higher activity in high-risk patients, such as the EGFR pathway, MAPK pathway, and PI3K pathway. The gene discussed is EGFR; the disease is neoplasm.